Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Carbonate
Patent
1994-03-22
1995-10-10
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Carbonate
424717, 514184, 514471, 514503, A61K 3300, A61K 31555, A61K 3134, A61K 3129
Patent
active
054569257
ABSTRACT:
The invention relates to a pharmaceutical composition in solid unit dosage form adapted for oral administration, comprising a salt formed between ranitidine and a complex of bismuth with a carboxylic acid selected from tartaric acid and citric acid together with an alkaline salt. For example the composition is in tablet form and comprises ranitidine bismuth citrate and sodium carbonate.
The composition shows improved disintegration and/or dissolution.
REFERENCES:
patent: 4608257 (1986-08-01), Teeter
patent: 5008256 (1991-04-01), Clitherow
patent: 5013560 (1991-05-01), Stentz et al.
patent: 5064857 (1991-11-01), Bertholdt et al.
patent: 5102665 (1992-04-01), Schaeffer
Goodman et al., The Pharmacological Basis of Therapeutics, 7th edition (1986) pp. 980-987.
Douglas Stephen J.
Heppenstall Colin R.
Smith Norman R.
Glaxo Group Limited
Henley III Raymond
LandOfFree
Pharmaceutical compositions containing furan derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing furan derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing furan derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2309277